David Tierney
Director/Board Member chez CATALYST PHARMACEUTICALS, INC.
Fortune : 6 M $ au 31/03/2024
Profil
David S.
Tierney was the founder of Oceana Therapeutics, Inc. (founded in 2008) and held the title of President, Chief Operating Officer & Director in 2011.
He is currently the President, CEO, Secretary, Treasurer & Director at Aramis Biosciences, Inc., an Independent Director at Catalyst Pharmaceuticals, Inc. since 2002, and a Director at Bimeda, Inc. since 2018.
Dr. Tierney has previously held positions as the President, Chief Executive Officer & Director at Valera Pharmaceuticals, Inc. from 2000 to 2007, President & Chief Executive Officer at Icon Bioscience, Inc. from 2014 to 2018, Chief Executive Officer at Pharma Two B Ltd.
in 2020, President & Chief Executive Officer at BioPharmX Corp.
from 2019 to 2020, and Senior Vice President-Drug Development at Roberts Pharmaceutical Corp.
from 1997 to 2000.
He has also served as a Director at Bioject Medical Technologies, Inc., Able Laboratories, Inc., Apricus Biosciences, Inc., Elan Pharmaceuticals LLC, Viatar CTC Solutions, Inc., Palvella Therapeutics, Inc., and Zevra Therapeutics, Inc. Additionally, Dr. Tierney was a Venture Partner at Signet Healthcare Partners LLC in 2013 and President of Biovail Technologies Ltd.
in 2000.
Dr. Tierney obtained his doctorate degree from the Royal College of Surgeons in 1987.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 08/04/2024 | 348 874 ( 0,30% ) | 6 M $ | 31/03/2024 | |
ZEVRA THERAPEUTICS, INC.
0,03% | 09/03/2023 | 10 835 ( 0,03% ) | 62 843 $ | 31/03/2024 |
Postes actifs de David Tierney
| Sociétés | Poste | Début |
|---|---|---|
| CATALYST PHARMACEUTICALS, INC. | Director/Board Member | 01/10/2002 |
Bimeda, Inc.
 Bimeda, Inc. Pharmaceuticals: MajorHealth Technology Bimeda, Inc. manufactures veterinary pharmaceuticals and animal health care products. The company has operations in the United Kingdom, Canada, the United States, Mexico, and Ireland. The firm was founded in 1997 and is headquartered in Oakbrook, IL | Director/Board Member | 01/06/2018 |
Aramis Biosciences, Inc.
 Aramis Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Aramis Biosciences is a clinical-stage immuno-ophthalmology biopharmaceutical company based in Medfield, MA. Aramis Biosciences is committed to developing disease-modifying therapy for ocular surface disease, starting with dry eye disease. The company's lead product candidate, A197, is a novel, first-in-class, topical immunomodulatory agent currently in a phase II clinical proof of concept for the treatment of dry eye disease. The company was founded in 2018 by Sunil Chauhan, Reza Dana, and the CEO is David S. Tierney. Aramis Biosciences was founded by leading experts in the fields of corneal disorders, ocular inflammation, and immunology from the Schepens Eye Research Institute of Mass Eye and Ear and the Department of Ophthalmology at Harvard Medical School, with support from Safar Partners, Dompé Farmaceutici S.p.A., and a leader in ophthalmic pharmaceuticals. | Chief Executive Officer | - |
Anciens postes connus de David Tierney
| Sociétés | Poste | Fin |
|---|---|---|
Pharma Two B Ltd.
 Pharma Two B Ltd. Pharmaceuticals: GenericHealth Technology Pharma Two B Ltd. operates as a biopharmaceutical company which focuses on developing treatments for Parkinson’s disease. The firm focuses on Fixed-Dose-combinations of two or more drugs with synergistic effects, providing clinical value and regulatory pathways. The company was founded by Ehud Marom and Nurit Livnah in December 2007 and is headquartered in Rehovot, Israel. | Chief Executive Officer | 01/01/2021 |
| TREX WIND-DOWN, INC. | Chief Executive Officer | 01/01/2020 |
Icon Bioscience, Inc.
 Icon Bioscience, Inc. Pharmaceuticals: MajorHealth Technology Icon Bioscience, Inc. develops and markets ophthalmic pharmaceuticals. It develops specialty pharmaceuticals targeting ophthalmic indications including macular edema, glaucoma, age-related macular degeneration and cataract surgery. The firm's pipeline includes IBI-10090, IBI-20089, IBI-60089, and IBI-80090. The company was founded by Vernon G. Wong and is headquartered in Newark, CA. | Chief Executive Officer | 01/03/2018 |
Signet Healthcare Partners LLC
 Signet Healthcare Partners LLC Investment ManagersFinance Signet Healthcare Partners LLC (Signet Healthcare Partners) is a private equity/venture capital subsidiary of Sanders Morris Harris Group Private Equity founded in 1998. The firm is headquartered in New York. | Corporate Officer/Principal | 01/03/2014 |
Oceana Therapeutics, Inc.
 Oceana Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Oceana Therapeutics, Inc. manufactures pharmaceuticals and medical devices. It develops and commercializes therapeutics with a focus on colorectal, gastroenterology, and urological diseases. The firm provides Deflux that is used for the treatment of Vesicoureteral reflux, urological conditions and Solesta which is used for the treatment of fecal incontinence. The company was founded in 2008 and is headquartered in Edison, NJ. | Founder | 01/12/2011 |
Formation de David Tierney
| Royal College of Surgeons | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| CATALYST PHARMACEUTICALS, INC. | Health Technology |
| ZEVRA THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 16 |
|---|---|
Bioject Medical Technologies, Inc.
 Bioject Medical Technologies, Inc. Medical SpecialtiesHealth Technology Bioject Medical Technologies, Inc. develops and manufactures needle-free injection therapy systems. Its products include Biojector 2000, Needle Free Injection System, ZetaJet, Drug Reconstitution System, and Needle-Free Vial Adapter. The company was founded in 1985 and is headquartered in Tigard, OR. | Health Technology |
Roberts Pharmaceutical Corp.
 Roberts Pharmaceutical Corp. Pharmaceuticals: OtherHealth Technology Roberts Pharmaceutical Corp. provides pharmaceutical products. It offers medicines for cardiovascular, gynecology. The company is headquartered in Eatontown, NJ. | Health Technology |
| Able Laboratories, Inc. | Health Technology |
Apricus Biosciences, Inc.
 Apricus Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Apricus Biosciences, Inc. is a biopharmaceutical company, which engages in the development and commercialization of product candidates in the areas of specialty urology and rheumatology. Its products include Vitaros and Femprox. The company was founded in 1987 and is headquartered in San Diego, CA. | Health Technology |
Valera Pharmaceuticals, Inc.
 Valera Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Valera Pharmaceuticals, Inc. develops and commercializes products for the treatment of urology and endocrine conditions, diseases and disorders. The Company was founded in 1972 and is located in Cranbury, NJ. | Health Technology |
Signet Healthcare Partners LLC
Signet Healthcare Partners LLC Investment ManagersFinance Signet Healthcare Partners LLC (Signet Healthcare Partners) is a private equity/venture capital subsidiary of Sanders Morris Harris Group Private Equity founded in 1998. The firm is headquartered in New York. | Finance |
Elan Pharmaceuticals, LLC
 Elan Pharmaceuticals, LLC Pharmaceuticals: MajorHealth Technology Elan Pharmaceuticals LLC develops and manufactures pharmaceutical products. It specializes in treatment of neurological and autoimmune diseases. The firm's drugs are used in the treatment of for Alzheimer's, Parkinson's, and rheumatoid arthritis diseases. The company is headquartered in South San Francisco, CA. | Health Technology |
Icon Bioscience, Inc.
Icon Bioscience, Inc. Pharmaceuticals: MajorHealth Technology Icon Bioscience, Inc. develops and markets ophthalmic pharmaceuticals. It develops specialty pharmaceuticals targeting ophthalmic indications including macular edema, glaucoma, age-related macular degeneration and cataract surgery. The firm's pipeline includes IBI-10090, IBI-20089, IBI-60089, and IBI-80090. The company was founded by Vernon G. Wong and is headquartered in Newark, CA. | Health Technology |
Viatar CTC Solutions, Inc.
 Viatar CTC Solutions, Inc. Medical SpecialtiesHealth Technology Viatar CTC Solutions, Inc. is a medical technology company, which engages in the treatment of patients with metastatic cancer. Its products include Viatar Therapeutic Oncopheresis System that removes circulating tumor cells from whole blood using label-free cross-flow filtration. The company was founded by Ilan K. Reich on December 18, 2007 and is headquartered in Lowell, MA. | Health Technology |
Bimeda, Inc.
Bimeda, Inc. Pharmaceuticals: MajorHealth Technology Bimeda, Inc. manufactures veterinary pharmaceuticals and animal health care products. The company has operations in the United Kingdom, Canada, the United States, Mexico, and Ireland. The firm was founded in 1997 and is headquartered in Oakbrook, IL | Health Technology |
| Biovail Technologies Ltd. | |
Oceana Therapeutics, Inc.
Oceana Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Oceana Therapeutics, Inc. manufactures pharmaceuticals and medical devices. It develops and commercializes therapeutics with a focus on colorectal, gastroenterology, and urological diseases. The firm provides Deflux that is used for the treatment of Vesicoureteral reflux, urological conditions and Solesta which is used for the treatment of fecal incontinence. The company was founded in 2008 and is headquartered in Edison, NJ. | Health Technology |
BioPharmX Corp.
 BioPharmX Corp. BiotechnologyHealth Technology BioPharmX Corp. is a specialty pharmaceutical company focused on developing prescription products utilizing its proprietary HyantX Topical Delivery System for dermatology indications. The HyantX delivery system is designed to stabilize and solubilize hydrophilic molecules in an anhydrous gel environment. The company was founded by James R. Pekarsky and Anja B. Krammer on August 30, 2010 and is headquartered in Campbell, CA. | Health Technology |
Palvella Therapeutics, Inc.
 Palvella Therapeutics, Inc. BiotechnologyHealth Technology Palvella Therapeutics, Inc. operates as a rare disease biopharmaceutical company. It develops and commercializes pathogenetically targeted therapies for rare genodermatoses with no approved treatments. Its products include QTORIN, PTX-022, PTX-367, and PTX-014. The company was founded by Wesley H. Kaupinen in 2015 and is headquartered in Wayne, PA. | Health Technology |
Aramis Biosciences, Inc.
Aramis Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Aramis Biosciences is a clinical-stage immuno-ophthalmology biopharmaceutical company based in Medfield, MA. Aramis Biosciences is committed to developing disease-modifying therapy for ocular surface disease, starting with dry eye disease. The company's lead product candidate, A197, is a novel, first-in-class, topical immunomodulatory agent currently in a phase II clinical proof of concept for the treatment of dry eye disease. The company was founded in 2018 by Sunil Chauhan, Reza Dana, and the CEO is David S. Tierney. Aramis Biosciences was founded by leading experts in the fields of corneal disorders, ocular inflammation, and immunology from the Schepens Eye Research Institute of Mass Eye and Ear and the Department of Ophthalmology at Harvard Medical School, with support from Safar Partners, Dompé Farmaceutici S.p.A., and a leader in ophthalmic pharmaceuticals. | Health Technology |
Pharma Two B Ltd.
Pharma Two B Ltd. Pharmaceuticals: GenericHealth Technology Pharma Two B Ltd. operates as a biopharmaceutical company which focuses on developing treatments for Parkinson’s disease. The firm focuses on Fixed-Dose-combinations of two or more drugs with synergistic effects, providing clinical value and regulatory pathways. The company was founded by Ehud Marom and Nurit Livnah in December 2007 and is headquartered in Rehovot, Israel. | Health Technology |
